Chemoinformaics analysis of trans-Chrysanthemal
Molecular Weight | 152.237 | nRot | 2 |
Heavy Atom Molecular Weight | 136.109 | nRig | 5 |
Exact Molecular Weight | 152.12 | nRing | 1 |
Solubility: LogS | -2.546 | nHRing | 0 |
Solubility: LogP | 2.952 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 0 | BPOL | 16.9193 |
QED | 0.438 |
Synth | 4.042 |
Natural Product Likeliness | 2.154 |
NR-PPAR-gamma | 0.046 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.082 |
Pgp-sub | 0.002 |
HIA | 0.007 |
CACO-2 | -4.439 |
MDCK | 0.0000211 |
BBB | 0.912 |
PPB | 0.605268 |
VDSS | 4.642 |
FU | 0.326138 |
CYP1A2-inh | 0.24 |
CYP1A2-sub | 0.242 |
CYP2c19-inh | 0.047 |
CYP2c19-sub | 0.798 |
CYP2c9-inh | 0.025 |
CYP2c9-sub | 0.128 |
CYP2d6-inh | 0.023 |
CYP2d6-sub | 0.196 |
CYP3a4-inh | 0.071 |
CYP3a4-sub | 0.32 |
CL | 11.711 |
T12 | 0.473 |
hERG | 0.007 |
Ames | 0.126 |
ROA | 0.018 |
SkinSen | 0.659 |
Carcinogencity | 0.023 |
EI | 0.983 |
Respiratory | 0.373 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.927521 |